Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
NBRV

Nabriva Therapeutics

$10.39

-0.59 (-5.37%)

17:20
07/28/17
07/28
17:20
07/28/17
17:20
Syndicate
Breaking Syndicate news story on Nabriva Therapeutics »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

Over a month ago
NBRV

Nabriva Therapeutics

07:13
07/11/17
07/11
07:13
07/11/17
07:13
Hot Stocks
Nabriva Therapeutics appoints Francesco Maria Lavino as Chief Commercial Officer »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

, TRVN

Trevena

$2.52

0.03 (1.20%)

08:06
06/26/17
06/26
08:06
06/26/17
08:06
Hot Stocks
Nabriva names CEO Colin Broom, Trevena CCO Carrie Bourow to board »

Nabriva Therapeutics…

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

TRVN

Trevena

$2.52

0.03 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

  • 26

    Sep

NBRV

Nabriva Therapeutics

$10.55

0.05 (0.48%)

07:03
06/26/17
06/26
07:03
06/26/17
07:03
Hot Stocks
Nabriva Therapeutics plc concludes tender offer for Nabriva shares »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 06

    Jul

NBRV

Nabriva Therapeutics

$10.50

1.19 (12.78%)

20:22
06/22/17
06/22
20:22
06/22/17
20:22
Initiation
Nabriva Therapeutics initiated at Cantor »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jul

NBRV

Nabriva Therapeutics

$9.20

0.26 (2.91%)

08:25
06/19/17
06/19
08:25
06/19/17
08:25
Conference/Events
Nabriva Therapeutics to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NBRV

Nabriva Therapeutics

$8.94

-0.53 (-5.60%)

07:31
06/16/17
06/16
07:31
06/16/17
07:31
Conference/Events
Nabriva Therapeutics to host analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

NBRV

Nabriva Therapeutics

$10.00

0.03 (0.30%)

04:55
05/25/17
05/25
04:55
05/25/17
04:55
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

NBRV

Nabriva Therapeutics

$9.97

0.41 (4.29%)

04:55
05/24/17
05/24
04:55
05/24/17
04:55
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

NBRV

Nabriva Therapeutics

$9.56

-0.23 (-2.35%)

11:15
05/23/17
05/23
11:15
05/23/17
11:15
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.